2 completed, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
Follow SAR: new trials by email Literature Review of SAR trials Research Report on SAR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis PG-011 nasal spray 0.6%(twice daily), Placebo - Seasonal Allergic Rhinitis, SAR | Phase 3 | Not yet recruiting | Prime Gene Therapeutics Co., Ltd. | 600 | 2025-09-15 | 2025-08-28 |
| Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. Vitamin D, PLACEBO - SAR, SARS Pneumonia | Phase 3 | Completed | Bioaraba Health Research Institute | 108 | 2020-11-09 | 2022-07-15 |
| Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies BDP HFA, Placebo nasal aerosol - Seasonal Allergic Rhinitis, SAR | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 715 | 2011-03-01 | 2015-02-20 |
Rhinitis, Allergic, Seasonal (2) · Hypersensitivity (1)
Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2) · Rhinitis (2) · Rhinitis, Allergic (2) · Hypersensitivity (1)
Beclomethasone (1) · Nasal Sprays (1) · Vitamin D (1) · alpha-ketoisovalerate dehydrogenase phosphatase (1) · apaflurane (1)
Bioaraba Health Research Institute (1) · Prime Gene Therapeutics Co., Ltd. (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
China (1) · Spain (1) · United States (1)